Biomarkers are measurable indicators that facilitate early and accurate diagnosis of dementia, guiding treatment and management.

Types of Biomarkers in Dementia

Common biomarkers include amyloid-beta and tau proteins measured via cerebrospinal fluid or imaging tests.

Genetic markers and blood-based biomarkers are emerging as less invasive options.

Advantages of Biomarker Testing

Biomarkers improve diagnostic accuracy, allowing differentiation between dementia types.

Early detection supports timely intervention and planning.

Challenges and Limitations

Testing can be costly and invasive, with accessibility varying widely.

Interpretation requires specialist knowledge, and false positives/negatives remain a concern.

Future Directions in Biomarker Research

Non-invasive blood tests and wearable monitoring technologies are under investigation.

Integrating biomarkers with cognitive and behavioral assessments may enhance care.